Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Hepatology Research

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1872-034X.2007.00216.xPMID 18039202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver transplantation for hepatocellular carcinoma

  2007cited by this paper
• Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan.

  2006cited by this paper
• Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis

  2005cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• Liver Cancer on the Rise

  2005cited by this paper
• Report of the 15th follow-up survey of primary liver cancer.

  2005cited by this paper
• Results of hepatic resection for hepatocellular carcinoma

  2004cited by this paper
• Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization

  2003cited by this paper
• Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults

  2003cited by this paper
• Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.

  2002cited by this paper
• Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.

  2002cited by this paper
• Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

  2002cited by this paper
• Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

  2002cited by this paper
• Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective

  2002cited by this paper
• Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.

  2002cited by this paper
• Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

  2002cited by this paper
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

  2002cited by this paper
• Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.

  2001cited by this paper
• Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

  2001cited by this paper
• Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.

  2001cited by this paper
• Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort.

  2001cited by this paper
• Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI

  2001cited by this paper
• Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.

  2001cited by this paper
• Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma

  2001cited by this paper
• Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis.

  2001cited by this paper
• Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

  2001cited by this paper
• Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

  2001cited by this paper
• Small Nodule Detection in Cirrhotic Livers: Evaluation with US, Spiral CT, and MRI and Correlation with Pathologic Examination of Explanted Liver

  2001cited by this paper
• Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

  2001cited by this paper
• Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosis: a meta‐analysis

  2001cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001cited by this paper
• Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

  2001cited by this paper
• Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients.

  2000cited by this paper
• Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.

  2000cited by this paper
• Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

  2000cited by this paper
• Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

  2000cited by this paper
• Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

  2000cited by this paper
• Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy.

  2000cited by this paper
• Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis

  2000cited by this paper
• Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon‐α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

  2000cited by this paper
• Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.

  1999cited by this paper
• Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature.

  1999cited by this paper
• Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

  1999cited by this paper
• Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response.

  1999cited by this paper
• [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].

  1999cited by this paper
• Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

  1999cited by this paper
• The effect of preoperative transcatheter hepatic arterial chemoembolization on disease‐free survival after hepatectomy for hepatocellular carcinoma

  1999cited by this paper
• Screening for hepatocellular carcinoma in patients with advanced cirrhosis

  1999cited by this paper
• Prognostic significance of anatomical resection and des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma

  1999cited by this paper
• Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.

  1999cited by this paper
• Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.

  1999cited by this paper
• Should hepatomas be treated with hepatic resection or transplantation?

  1999cited by this paper
• Preoperative chemoembolization of hepatocellular carcinoma: a comparative study.

  1998cited by this paper
• Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma

  1998cited by this paper
• Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients.

  1998cited by this paper
• A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.

  1998cited by this paper
• Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy

  1997cited by this paper
• Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy

  1997cited by this paper
• Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates.

  1997cited by this paper
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

  1997cited by this paper
• Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

  1997cited by this paper
• A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma

  1996cited by this paper
• Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?

  1996cited by this paper
• Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

  1996cited by this paper
• Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.

  1996cited by this paper
• Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography.

  1996cited by this paper
• Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

  1996cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Repeat hepatectomy for recurrent hepatocellular carcinoma

  1996cited by this paper
• Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

  1995cited by this paper
• Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

  1994cited by this paper
• Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein.

  1994cited by this paper
• Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients.

  1994cited by this paper
• Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization.

  1993cited by this paper
• Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.

  1993cited by this paper
• Acute pain management: operative or medical procedures and trauma.

  1993cited by this paper
• Management of hepatocellular carcinoma.

  1992cited by this paper
• Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy

  1992cited by this paper
• Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

  1991cited by this paper
• Transcatheter oily chemoembolization of hepatocellular carcinoma.

  1989cited by this paper
• Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients

  1985cited by this paper
• Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

  1981cited by this paper
• HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS. A Prospective Study of 22 707 Men in Taiwan

  1981cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper

• Dynamic changes in the characteristics of hepatocellular carcinoma among Japanese patients: Increasing incidence of cases without liver fibrosis

  2025cites this paper
• Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification

  2025cites this paper
• The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

  2024cites this paper
• Utility of Quantitative Assessment of Tc-99m-diethylenetriamine-penta-acetic acid-galactosyl Human Serum Albumin SPECT/CT in the Identification of Severe Liver Fibrosis: Its Complementary Diagnostic Value with Other Liver Function Indices

  2024cites this paper
• Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy

  2024cites this paper
• Novel Blood-Based Biomarkers for HCC

  2024cites this paper
• Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

  2023cites this paper
• Screening of liver cancer with abbreviated MRI

  2023cites this paper
• Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality

  2023cites this paper
• Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review

  2023cites this paper
• Reveal the mechanisms of prescriptions for liver cancer' treatment based on two illustrious senior TCM physicians.

  2023cites this paper
• Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer

  2022cites this paper
• Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis

  2022cites this paper
• Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma

  2022cites this paper
• Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference Algorithm: Retrospective Study

  2022cites this paper
• Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey

  2021cites this paper
• Transmediastinal, intrapericardial inferior vena cava approach based on anatomical landmarks for hepatectomy using total hepatic vascular exclusion

  2021cites this paper
• JMIR Medical Informatics

  2021cites this paper
• Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma

  2021cites this paper
• Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

  2021cites this paper
• Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma

  2021influential citation
• Anatomic Resection for Hepatocellular Carcinoma: Prognostic Impact Assessed from Recurrence Treatment

  2021cites this paper
• Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.

  2020cites this paper
• Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma

  2020cites this paper
• Data driven decision-making for older patients with hepatocellular carcinoma.

  2020cites this paper
• Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment

  2020cites this paper
• Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation

  2020cites this paper
• Impact of systematic segmentectomy for small hepatocellular carcinoma

  2020cites this paper
• A Novel Noninvasive Method for Predicting Liver Fibrosis by Quantifying the Estrangement of Indocyanine Green Retention Rate and Tc-99m-diethylenetriamine-penta-acetic Acid-galactosyl Human Serum Albumin Scintigraphy

  2020cites this paper
• Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

  2020cites this paper
• Avoidance of bile duct injury during laparoscopic liver cyst fenestration using indocyanine green: A case report

  2020cites this paper
• HCC in Patients with NAFLD/NASH

  2020cites this paper
• BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA.

  2020cites this paper
• The impact of age and ageing on hepatocarcinoma surgery: Short‐ and long‐term outcomes in a multicentre propensity‐matched cohort

  2019cites this paper
• Validation of a novel model for the early detection of hepatocellular carcinoma

  2019cites this paper
• Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future

  2019cites this paper
• Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.

  2019cites this paper
• Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virus

  2019cites this paper
• Endoscopic hepatic resection and endoscopic radiofrequency ablation as initial treatments for hepatocellular carcinoma within the Milan criteria

  2019cites this paper
• Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma.

  2019cites this paper
• Assessment of the effect of the Aquamantys® system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching

  2019cites this paper
• Comparison of parallel and crossed placement of antennas in microwave ablation of 3–5 cm hepatocellular carcinoma

  2019cites this paper
• Hepatocellular Carcinoma: Diagnosis and Prognosis

  2019cites this paper
• Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation

  2019cites this paper
• Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

  2019cites this paper
• Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.

  2018cites this paper
• Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report

  2018cites this paper
• Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver

  2018cites this paper
• Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.

  2018cites this paper
• Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting

  2018cites this paper
• The role of imaging in screening special feaTure: review arTicle hepatocellular carcinoma surveillance with ultrasound— cost-effectiveness, high-risk populations, uptake

  2018cites this paper
• Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension

  2018cites this paper
• Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma

  2018cites this paper
• Hepatocellular carcinoma surveillance with ultrasound-cost-effectiveness, high-risk populations, uptake.

  2018cites this paper
• Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients

  2018cites this paper
• Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years

  2018cites this paper
• Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis

  2018cites this paper
• Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma

  2018cites this paper
• Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.

  2018cites this paper
• Risk stratification using a novel liver functional reserve score of combination prothrombin time–international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma

  2018cites this paper
• Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma

  2018cites this paper
• Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.

  2018cites this paper
• Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years

  2017cites this paper
• Instructions for use Title Analysis of the risk factors for early death due to disease recurrence or progression within 1 year afterhepatectomy in patients with hepatocellular carcinoma

  2017cites this paper
• ICG Clearance Test and 99mTc-GSA SPECT/CT Fusion Images

  2017cites this paper
• Surveillance rates for hepatocellular carcinoma among patients with cirrhosis, chronic hepatitis B, and chronic hepatitis C based on Japanese claims database

  2017cites this paper
• Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey

  2017cites this paper
• Serum levels of anti-sperm-associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma.

  2017cites this paper
• Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma

  2017cites this paper
• Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?

  2017cites this paper
• Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance

  2017cites this paper
• Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study

  2017cites this paper
• Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.

  2017cites this paper
• New concepts in embolotherapy of HCC

  2017cites this paper
• Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort study

  2017cites this paper
• Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey

  2017cites this paper
• Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ

  2017cites this paper
• Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function

  2017cites this paper
• Current Approaches to the Treatment of Early Hepatocellular Carcinoma

  2017cites this paper
• Usefulness of early vascular phase images from contrast‐enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma

  2016cites this paper
• Preventive Effect of Geraniol on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats

  2016cites this paper
• Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan

  2016cites this paper
• Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child–Pugh C liver cirrhosis?: A multicenter study

  2016cites this paper
• Erratum to: Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

  2016cites this paper
• Evaluating the current surgical strategies for hepatocellular carcinoma

  2016cites this paper
• The serum level of NX-DCP-R, but not DCP, is not increased in alcoholic liver disease without hepatocellular carcinoma

  2016cites this paper
• Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma

  2016cites this paper
• Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

  2015cites this paper
• Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.

  2015cites this paper
• Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma.

  2015cites this paper
• Foreword

  2015cites this paper
• Complications following hepatectomy.

  2015cites this paper
• Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma

  2015cites this paper
• Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

  2015cites this paper
• The Korean guideline for hepatocellular carcinoma

  2015cites this paper
• Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.

  2015cites this paper
• Trans-arterial Chemo-Embolization in Treating Elderly Patients with Hepatocellular Carcinoma.

  2015cites this paper
• Diagnosis of Hepatocellular Carcinoma Nodules in Patients With Chronic Liver Disease Using Contrast‐Enhanced Sonography

  2015cites this paper
• Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours

  2015cites this paper
• Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review.

  2015cites this paper